Article
Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association - 1 May 2005
Kunnari A, Ukkola O, Kesäniemi Y A
Abstract excerpt
AIMS: Resistin is a hormone secreted by adipocytes and it is also expressed in monocytes. Resistin has been found to increase insulin resistance, a key feature in Type 2 diabetes. The aim of this study was to investigate whether resistin polymorphisms are associated with Type 2 diabetes and its clinical characteristics. METHODS: We studied the allele and genotype frequencies of the single-nucleotide polymorphisms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
